US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PIMCO DYNAMIC INCOME STRATEGY FUND

20.21

-0.1900-0.93%

Post-market: 20.210.00000.00%19:30 EDT

Volume:140.96K

Turnover:2.85M

Market Cap:903.53M

PE:3.81

High:20.41

Open:20.32

Low:20.11

Close:20.40

52wk High:25.21

52wk Low:18.47

Shares:44.71M

Float Shares:44.71M

Volume Ratio:0.92

T/O Rate:0.32%

Dividend:4.57

Dividend Rate:22.62%

EPS(TTM):5.31

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer

TRANSCENTA-B Reveals New Data Showing Potent Anti-Tumor Activity of Novel LIV1 ADC TST013 in Prostate Cancer and ER-Positive/HER2-Negative Breast Cancer PDX Models

Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026

Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform

Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/PDX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDX\",,,,,undefined,":{"symbol":"PDX","market":"US","secType":"STK","nameCN":"PIMCO DYNAMIC INCOME STRATEGY FUND","latestPrice":20.21,"timestamp":1790193600000,"preClose":20.4,"halted":0,"volume":140958,"hourTrading":{"tag":"盘后","latestPrice":20.21,"preClose":20.21,"latestTime":"19:30 EDT","volume":45,"amount":909.45,"timestamp":1790206206990,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.009313725490195967,"floatShares":44706949,"shares":44706949,"eps":5.31,"marketStatus":"Not Yet Opened","change":-0.19,"latestTime":"09-23 16:00:00 EDT","open":20.32,"high":20.41,"low":20.11,"amount":2854003.971852,"amplitude":0.014706,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.31,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790236800000},"marketStatusCode":0,"adr":0,"listingDate":1548824400000,"exchange":"NYSE","adjPreClose":20.4,"dividendRate":0.22622,"postHourTrading":{"tag":"盘后","latestPrice":20.21,"preClose":20.21,"latestTime":"19:30 EDT","volume":45,"amount":909.45,"timestamp":1790206206990,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.91504},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDX\",,,,,undefined,":{"symbol":"PDX","floatShares":44706949,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.91504,"shares":44706949,"dividePrice":4.5719,"high":20.41,"amplitude":0.014706,"preClose":20.4,"low":20.11,"week52Low":18.47,"pbRate":"--","week52High":25.21,"institutionHeld":0,"latestPrice":20.21,"eps":5.31,"divideRate":0.22622,"volume":140958,"delay":0,"ttmEps":5.31,"open":20.32,"prevYearClose":18.78,"prevWeekClose":20.69,"prevMonthClose":21.82,"prevQuarterClose":20.82,"fiveDayClose":20.66,"twentyDayClose":21.67,"sixtyDayClose":20.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PDX\",params:#limit:5,,,undefined,":[{"date":"2026-09-11","symbol":"PDX","amount":0.1334,"announcedDate":"2026-09-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-11","defaultRemindTime":1789133400000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-01","payableDate":"2026-09-11","currency":"USD","dateTimestamp":1789099200000,"payDate":"2026-10-01"},{"date":"2026-08-13","symbol":"PDX","amount":0.1334,"announcedDate":"2026-08-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-13","defaultRemindTime":1786627800000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-01","payableDate":"2026-08-13","currency":"USD","dateTimestamp":1786593600000,"payDate":"2026-09-01"},{"date":"2026-07-13","symbol":"PDX","amount":0.1334,"announcedDate":"2026-07-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-13","defaultRemindTime":1783949400000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-03","payableDate":"2026-07-13","currency":"USD","dateTimestamp":1783915200000,"payDate":"2026-08-03"},{"date":"2026-06-11","symbol":"PDX","amount":0.1334,"announcedDate":"2026-06-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-11","defaultRemindTime":1781184600000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-01","payableDate":"2026-06-11","currency":"USD","dateTimestamp":1781150400000,"payDate":"2026-07-01"},{"date":"2026-05-11","symbol":"PDX","amount":0.1334,"announcedDate":"2026-05-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-11","defaultRemindTime":1778506200000,"name":"PIMCO DYNAMIC INCOME STRATEGY FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-01","payableDate":"2026-05-11","currency":"USD","dateTimestamp":1778472000000,"payDate":"2026-06-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-08","recordDate":"2023-12-11","paymentDate":"2024-01-02","value":0.22,"currency":"USD"},{"executeDate":"2024-03-08","recordDate":"2024-03-11","paymentDate":"2024-04-01","value":0.26,"currency":"USD"},{"executeDate":"2024-04-10","recordDate":"2024-04-11","paymentDate":"2024-05-01","value":0.1133,"currency":"USD"},{"executeDate":"2024-05-10","recordDate":"2024-05-13","paymentDate":"2024-06-03","value":0.1133,"currency":"USD"},{"executeDate":"2024-06-13","recordDate":"2024-06-13","paymentDate":"2024-07-01","value":0.1133,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PDX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629833979","title":"Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629833979","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629833979?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:00","pubTimestamp":1776942000,"startTime":"0","endTime":"0","summary":"PRINCETON, N.J. and SUZHOU, China, April  23, 2026 (GLOBE NEWSWIRE) -- Transcenta Therapeutics (HKEX: 06628), a global clinical stage biopharmaceutical company with fully-integrated capabilities in di","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/23/3279725/0/en/Transcenta-Therapeutics-Presents-New-Data-for-its-Novel-LIV1-Targeting-ADC-TST013-Demonstrating-Potent-Anti-Tumor-Activity-in-PDX-Models-of-Prostate-Cancer-and-ER-Positive-HER2-Neg.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","PDX","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187613037","title":"TRANSCENTA-B Reveals New Data Showing Potent Anti-Tumor Activity of Novel LIV1 ADC TST013 in Prostate Cancer and ER-Positive/HER2-Negative Breast Cancer PDX Models","url":"https://stock-news.laohu8.com/highlight/detail?id=1187613037","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187613037?lang=en_us&edition=fundamental","pubTime":"2026-04-23 07:06","pubTimestamp":1776899191,"startTime":"0","endTime":"0","summary":"TRANSCENTA-B (06628) announced the presentation of preclinical data for its self-developed LIV1 Antibody-Drug Conjugate (ADC) at the 2026 AACR Annual Meeting. The data demonstrated potent anti-tumor...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06628","09939","ADC","159938","BK1515","PDX","BK4231","BK4080","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629830048","title":"Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629830048","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629830048?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855600,"startTime":"0","endTime":"0","summary":"Data showcase advances across oncology pipeline including pan-mutant BRAF, CBL-B and AURKA programs Presentations reinforce potential of degraders to overcome limitations of inhibitors and expand ther","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/22/3278794/0/en/Nurix-Therapeutics-Announces-New-Preclinical-Data-Highlighting-Breadth-of-Targeted-Protein-Degradation-Pipeline-at-AACR-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","BK4139","NRIX","PDX","BK4135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629362056","title":"Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2629362056","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629362056?lang=en_us&edition=fundamental","pubTime":"2026-04-22 00:00","pubTimestamp":1776787200,"startTime":"0","endTime":"0","summary":"Presentation of additional analyses from FAP-Exd (AVA6103) study shows robust activity in PDX models with low FAP expression and more favorable kinetic profile compared to the marketed antibody-drug c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/21/3278250/0/en/Avacta-data-at-AACR-2026-underline-favorable-profile-of-AVA6103-and-advantages-of-pre-CISION-delivery-platform.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","PDC","BK4080","BK4123","BK4231","CRC","PDX","LU0456854461.SGD","BK4181","PK","ADC","BK4218","LU0266512127.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628279482","title":"Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628279482","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628279482?lang=en_us&edition=fundamental","pubTime":"2026-04-20 07:45","pubTimestamp":1776642300,"startTime":"0","endTime":"0","summary":"STRO-004 demonstrates robust and consistent antitumor activity across multiple TF-expressing solid tumor PDX models, with improved efficacy versus benchmark ADCs STRO-006 and STRO-227 show meaningful,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/19/3276676/0/en/Sutro-Biopharma-Presents-Promising-Preclinical-Data-Across-its-Pipeline-of-Next-Generation-Single-and-Dual-Payload-ADC-Programs-at-AACR-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDX","BK4139","BK4231","ADC","BK4080","STRO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":25,"code":"91000000","status":"200"}]}}